Literature DB >> 11059860

Hepatic microvascular features in experimental cirrhosis: a structural and morphometrical study in CCl4-treated rats.

P Onori1, S Morini, A Franchitto, R Sferra, D Alvaro, E Gaudio.   

Abstract

BACKGROUND/AIMS: In this study, a detailed morphometrical analysis of the hepatic microvasculature in the different zones of hepatic parenchyma was performed in normal and cirrhotic rat liver (CCl4-induced). The aims were to detect, in CCl4-induced cirrhosis, the real presence of the "capillarization" of hepatic sinusoids and to assess alterations of the sinusoid/parenchyma ratio within the nodule.
METHODS: Cirrhosis was promoted by controlled intragastric CCl4 administration. Scanning electron microscopy of the vascular corrosion cast technique associated with light microscopy and transmission electron microscopy were used.
RESULTS: Evidence of connective tissue in the space of Disse was found only in sinusoids located near portal tracts or large fibrotic areas, and this was also confirmed by laminin immunohistochemistry. In contrast, all the intranodular sinusoids lacked real basal membrane and connective fibers in the space of Disse and, displayed normal fenestrations. The parenchymal area, sinusoidal area, mean sinusoidal area, sinusoidal perimeter, hepatocyte area and the reciprocal ratios were all considered in the morphometrical analysis. The sinusoids were of uniform size in the periportal, periseptal and pericentral areas of the cirrhotic liver without the typical zonal differences of the normal liver. The areas occupied by sinusoids per unit of parenchyma and the sinusoid/hepatocyte interfaces disposable for metabolic exchanges were markedly smaller (p<0.01) in cirrhotic than normal liver.
CONCLUSION: Our findings indicate that capillarization of hepatic sinusoids occurs only in very limited regions of the cirrhotic parenchyma, and thus this phenomenon does not have relevant functional consequences. Furthermore, the cirrhotic parenchyma appears not to be supplied by sinusoids and lacks features of zonation, which is a condition that could play a major role in the development and progression of liver failure.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11059860     DOI: 10.1034/j.1600-0641.2000.033004555.x

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  23 in total

Review 1.  Hagen-Poiseuille's law: The link between cirrhosis, liver stiffness, portal hypertension and hepatic decompensation.

Authors:  Gerond Lake-Bakaar; Muneeb Ahmed; Amy Evenson; Alan Bonder; Salomao Faintuch; Vinay Sundaram
Journal:  World J Hepatol       Date:  2015-01-27

2.  Anti-angiogenesis in hepatocellular carcinoma treatment: current evidence and future perspectives.

Authors:  Martin-Walter Welker; Joerg Trojan
Journal:  World J Gastroenterol       Date:  2011-07-14       Impact factor: 5.742

3.  Fractal and Fourier analysis of the hepatic sinusoidal network in normal and cirrhotic rat liver.

Authors:  Eugenio Gaudio; Slawomir Chaberek; Andrea Montella; Luigi Pannarale; Sergio Morini; Gilnardo Novelli; Federica Borghese; Davide Conte; Kazimierz Ostrowski
Journal:  J Anat       Date:  2005-08       Impact factor: 2.610

4.  Pathological mechanisms of alcohol-induced hepatic portal hypertension in early stage fibrosis rat model.

Authors:  Jian Li; Jian-Zhao Niu; Ji-Feng Wang; Yu Li; Xiao-Hua Tao
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

5.  Hypoxia, angiogenesis and liver fibrogenesis in the progression of chronic liver diseases.

Authors:  Claudia Paternostro; Ezio David; Erica Novo; Maurizio Parola
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

Review 6.  Management of Hepatocellular Carcinoma in Cirrhotic Patients with Portal Hypertension: Relevance of Hagen-Poiseuille's Law.

Authors:  Gerond Lake-Bakaar; Muneeb Ahmed; Amy Evenson; Alan Bonder; Salomao Faintuch; Vinay Sundaram
Journal:  Liver Cancer       Date:  2014-10       Impact factor: 11.740

7.  Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis.

Authors:  Yosui Tamaki; Yukiomi Nakade; Taeko Yamauchi; Yuichi Makino; Shiro Yokohama; Mitsuyoshi Okada; Kazunobu Aso; Hiroyuki Kanamori; Tomohiko Ohashi; Ken Sato; Haruhisa Nakao; Masakazu Haneda; Masashi Yoneda
Journal:  J Gastroenterol       Date:  2012-08-14       Impact factor: 7.527

8.  Myocardial mitochondrial oxidative stress and dysfunction in intense exercise: regulatory effects of quercetin.

Authors:  Chao Gao; Xiaoqian Chen; Juan Li; Yanyan Li; Yuhan Tang; Liang Liu; Shaodan Chen; Haiyan Yu; Liegang Liu; Ping Yao
Journal:  Eur J Appl Physiol       Date:  2013-12-25       Impact factor: 3.078

9.  Agaricus blazei Murill as an efficient hepatoprotective and antioxidant agent against CCl4-induced liver injury in rats.

Authors:  Abeer M Al-Dbass; Sooad K Al-Daihan; Ramesa Shafi Bhat
Journal:  Saudi J Biol Sci       Date:  2012-04-01       Impact factor: 4.219

10.  An intravital microscopic study of the hepatic microcirculation in cirrhotic mice models: relationship between fibrosis and angiogenesis.

Authors:  Eline Vanheule; Anja M Geerts; Jacques Van Huysse; Daphné Schelfhout; Marleen Praet; Hans Van Vlierberghe; Martine De Vos; Isabelle Colle
Journal:  Int J Exp Pathol       Date:  2008-12       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.